Fourth Quarter Update The Company also provided an update on several topics related to its fiscal 2025 fourth quarter, which...
Announces
BATON ROUGE, La., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of...
Fulcrum Therapeutics, Inc. ― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of...
For Fforme, too, the prospect of more industry support is enticing. “We’re honoured to take part in the inaugural KFN...
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide...
BATON ROUGE, La., April 24, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of...
